1971
DOI: 10.1136/jnnp.34.1.25
|View full text |Cite
|
Sign up to set email alerts
|

Linoleate metabolism in multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
23
0
1

Year Published

1976
1976
1995
1995

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(25 citation statements)
references
References 17 publications
1
23
0
1
Order By: Relevance
“…9 The levels of arachidonate in normal serum are low, and it does not seem that the correlation between linoleate and arachidonate in the normal red cell would arise simply from the relative amounts of these acids in the plasma. Indeed, much of the arachidonate in the red cell is found in the acidic phospholipids, phosphatidylserine and phosphatidylethanolamine," of which the levels are low in the serum lipoproteins.…”
Section: Discussionmentioning
confidence: 99%
“…9 The levels of arachidonate in normal serum are low, and it does not seem that the correlation between linoleate and arachidonate in the normal red cell would arise simply from the relative amounts of these acids in the plasma. Indeed, much of the arachidonate in the red cell is found in the acidic phospholipids, phosphatidylserine and phosphatidylethanolamine," of which the levels are low in the serum lipoproteins.…”
Section: Discussionmentioning
confidence: 99%
“…(1) Since it is well recognised that the fatty acid composition of the brain can be altered by changes in the dietary intake of different fatty acids (31,32) and the supplementation of the diet leads to an increase in the serum level of this fatty acid (33), it would seem reasonable to supplement the diet of young children found to have the 'MS type' of E-UFA result with ylinolenate. This would convert their membranes (including oligodendrocyte membranes) to normal, and since the human brain goes on myelinating until at least 16 years of age, lead to the laying down of normal as opposed to 'MS type' myelin, obviating susceptibility to de velopment of MS.…”
Section: Discussionmentioning
confidence: 99%
“…This was however challenged by the explanation that this tissue already contained microscopic plaques of demyelination and thus showed changes secondary to pathology [38]. Work on serum fat composition (table l ) has produced conflicting results [39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54], Most studies are on a small number of cases, and selection of control subjects has not always been ade quate. Often, no distinction between subjects in remission or relapse has been made.…”
Section: Biochemical Studiesmentioning
confidence: 99%